These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1859658)

  • 21. No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study.
    Milman N; Graudal N; Grode G; Munch E
    J Intern Med; 1994 Sep; 236(3):285-90. PubMed ID: 8077885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids.
    Wolthers OD; Pedersen S
    Pediatrics; 1992 May; 89(5 Pt 1):839-42. PubMed ID: 1579391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group.
    Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T
    Gastroenterology; 1996 Jan; 110(1):45-51. PubMed ID: 8536887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis.
    Guenther L; Solomon AR; Voorhees JJ
    Cutis; 1981 Oct; 28(4):461-2, 464, 467. PubMed ID: 7030645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of budesonide and beclomethasone dipropionate sprays in the treatment of seasonal allergic rhinitis.
    McArthur JG
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):537-42. PubMed ID: 7895388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial).
    Hartwig S; Lindén M; Laurent C; Vargö AK; Lindqvist N
    J Laryngol Otol; 1988 Feb; 102(2):148-51. PubMed ID: 3279143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-halogenated glucocorticoids in the treatment of psoriasis].
    Tølløfsrud A; Malmsten LA
    Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):560-1. PubMed ID: 6760456
    [No Abstract]   [Full Text] [Related]  

  • 28. Budesonide powder administration for the treatment of grass-pollen-induced allergic rhinitis.
    Pedersen B; Larsen BB; Dahl R; Hedbys L; Mygind N
    Allergy; 1994 Dec; 49(10):855-60. PubMed ID: 7709995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budesonide - a new steroid for intranasal use. A double-blind clinical comparison between budesonide and placebo in patients with seasonal allergic rhinitis.
    Warland A; Møller P; Lindqvist N
    Allergy; 1981 Aug; 36(6):425-8. PubMed ID: 7032343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of treatment of eczematous otitis externa with hydrocortisonum-aerosol].
    Klonowski S; Orzelski L; Golabek W; Czop S
    Pol Tyg Lek; 1972; 27(15):573-4. PubMed ID: 5022604
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis.
    Löfberg R; Danielsson A; Suhr O; Nilsson A; Schiöler R; Nyberg A; Hultcrantz R; Kollberg B; Gillberg R; Willén R; Persson T; Salde L
    Gastroenterology; 1996 Jun; 110(6):1713-8. PubMed ID: 8964395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budesonide - a new nasal steroid.
    Pipkorn U; Rundcrantz H; Lindqvist N
    Rhinology; 1980 Dec; 18(4):171-5. PubMed ID: 7010515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of perennial rhinitis with a new, non-halogenated, topical, aerosol packed, steroid, Budesonide.
    Balle VH; Pedersen U; Engby B
    Acta Otolaryngol; 1982; 94(1-2):169-73. PubMed ID: 7124383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children.
    Wolthers OD; Pedersen S
    Allergy; 1994 Feb; 49(2):96-9. PubMed ID: 8172365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler.
    Field HV; Jenkinson PM; Frame MH; Warner JO
    Arch Dis Child; 1982 Nov; 57(11):864-6. PubMed ID: 6756319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventions for acute otitis externa.
    Kaushik V; Malik T; Saeed SR
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004740. PubMed ID: 20091565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis.
    Danielsson A; Löfberg R; Persson T; Salde L; Schiöler R; Suhr O; Willén R
    Scand J Gastroenterol; 1992; 27(1):9-12. PubMed ID: 1736348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythema-multiforme-like contact dermatitis from budesonide.
    Stingeni L; Caraffini S; Assalve D; Lapomarda V; Lisi P
    Contact Dermatitis; 1996 Feb; 34(2):154-5. PubMed ID: 8681557
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
    Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
    Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.